Pascale Gaussem
Overview
Explore the profile of Pascale Gaussem including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
143
Citations
2336
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gendron N, Planquette B, Roche A, Chocron R, Helley D, Philippe A, et al.
Stem Cell Rev Rep
. 2025 Mar;
PMID: 40085375
Pulmonary embolism (PE) is a life-threatening condition with long-term complications, including residual pulmonary vascular obstruction (RPVO). RPVO is associated with an increased risk of venous thromboembolism recurrence, chronic symptoms, and...
2.
Smadja D, Roux de Bezieux J, Peronino C, Jilet L, Ivak P, Pya Y, et al.
ASAIO J
. 2025 Feb;
PMID: 40019017
This study aimed to assess platelet activation following implantation of the Aeson bioprosthetic total artificial heart (A-TAH). We monitored plasma levels of platelet activation markers in patients receiving A-TAH support...
3.
El Hamaoui D, Marchelli A, Gandrille S, Reboul E, Stepanian A, Palmier B, et al.
Commun Biol
. 2025 Feb;
8(1):316.
PMID: 40011679
Increased levels of soluble endoglin (sEng) are found in serum, plasma, and urine of preeclampsia patients. sEng is released from membrane-bound endoglin through the proteolytic activity of metalloproteases, but its...
4.
Smadja D, Mauge L, Rancic J, Gaussem P, Feraud O, Oudrhiri N, et al.
Stem Cell Rev Rep
. 2024 Nov;
21(2):581-588.
PMID: 39612122
The discovery of endothelial progenitor cells has revolutionized our understanding of postnatal blood vessel formation, with endothelial colony-forming cells (ECFCs) emerging as key players in vasculogenesis. Among various ECFC sources,...
5.
Eyraud D, Philippe A, Guerin C, Sarmiento I, Suner L, Puybasset L, et al.
Stem Cell Rev Rep
. 2024 Oct;
21(1):276-279.
PMID: 39377987
No abstract available.
6.
Gendron N, Helley D, Rousselot P, Siguret V, Gaussem P, James C, et al.
Res Pract Thromb Haemost
. 2024 Sep;
8(6):102547.
PMID: 39309230
No abstract available.
7.
Demagny J, Poirault-Chassac S, Ilsaint D, Marchelli A, Gomila C, Ouled-Haddou H, et al.
J Cell Mol Med
. 2024 Sep;
28(18):e70055.
PMID: 39304946
From haematopoietic stem cells to megakaryocytes (Mks), cells undergo various mechanical forces that affect Mk differentiation, maturation and proplatelet formation. The mechanotransductor PIEZO1 appears to be a natural candidate for...
8.
Lefebvre C, Luneau S, Bentounes N, Mauge L, Dumont A, Gaussem P, et al.
Ann Biol Clin (Paris)
. 2024 Sep;
82(4):451-460.
PMID: 39238419
Edoxaban is a direct oral anticoagulant available in Europe but not in France. Given the high tourist traffic in France, understanding the pharmacology of edoxaban and the availability of its...
9.
Peronino C, Rivet N, Itzhar-Baikian N, Philippe A, Joly B, Roux de Bezieux J, et al.
Ann Biol Clin (Paris)
. 2024 Aug;
82(4):361-375.
PMID: 39210589
The assessment of von Willebrand factor (VWF) multimer distribution, particularly following the implantation of circulatory support devices, is a crucial parameter in hemostasis. Our study aimed to evaluate the semi-automated...
10.
Jourdi G, Hulot J, Gaussem P
Expert Opin Drug Metab Toxicol
. 2024 Jul;
20(8):749-764.
PMID: 38980768
Introduction: Aspirin and anti-P2Y12 are widely prescribed in cardiovascular patients, often in combination with proton pump inhibitors (PPIs) to limit the risk of upper gastrointestinal bleedings. The potential interaction between...